Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gurling

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|August 3, 1993
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyC Routledge, J Gurling, I K Wright, et al.
European Journal of Pharmacology|April 4, 1995
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190C Routledge, J Gurling, M A Ashworth-Preece, et al.
Neuropharmacology|March 1, 1994
In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor functionC Routledge, J Hartley, J Gurling, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|August 3, 1993
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyC Routledge, J Gurling, I K Wright, et al.
European Journal of Pharmacology|April 4, 1995
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190C Routledge, J Gurling, M A Ashworth-Preece, et al.
Neuropharmacology|March 1, 1994
In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor functionC Routledge, J Hartley, J Gurling, et al.
Pageof 1